FC13A - Overview: Factor 13a Immunostain, Technical Component Only
Aiding in the identification of acquired digital fibrokeratomas, angiofibromas, and oral fibroma, and a proportion of cells in histiocytomas
FOXP3 - Overview: FOXP3 Immunostain, Technical Component Only
Classification of leukemias and lymphomas
FGFRC - Overview: Fibroblast Growth Factor Receptor 1, Immunostain, Technical Component Only
Classification of a subset of lung squamous cell carcinoma
EMAI - Overview: Epithelial Membrane Antigen (EMA) Immunostain, Technical Component Only
Recognizing epithelial derivation of poorly differentiated malignant tumors Subtyping intraductal papillary mucinous neoplasms when used in conjunction with mucin (MUC) 2, MUC5AC and MUC6
ERG - Overview: ERG Immunostain, Technical Component Only
Identification of erythroblast transformation specific (ETS)-related gene (ERG) protein expression
ECADB - Overview: E-Cadherin Immunostain, Bone Marrow, Technical Component Only
Differentiation between lobular and ductal neoplasms of the breast
EBV - Overview: Epstein-Barr Virus (EBV) In Situ Hybridization, Technical Component Only
Detection of Epstein-Barr virus (EBV)-encoded RNA in the diagnosis of EBV-associated conditions
FENR - Overview: Fentanyl Screen with Reflex, Random, Urine
Screening for drug abuse or use involving fentanyl and confirmation of fentanyl if present in the screen
PBU - Overview: Lead, 24 Hour, Urine
Detecting clinically significant lead exposure in 24-hour specimens This test is not a substitute for blood lead screening.
INSFT - Overview: Insulin, Free and Total, Serum
Assessing free (bioactive) insulin concentrations in patients with known or suspected anti-insulin antibodies
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...